1.
Berden F, van Zwietering I, Maan R, de Knegt R, Kievit W, Drenth J. High Risk of Infection During Triple Therapy with First- Generation Protease Inhibitors: A Nationwide Cohort Study. JGLD [Internet]. 1Jun.2016 [cited 7Feb.2025];25(2):197-04. Available from: https://www.jgld.ro/jgld/index.php/jgld/article/view/1106